AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
2.970
-0.090 (-2.94%)
At close: Jul 19, 2024, 4:00 PM
3.000
+0.030 (1.01%)
Pre-market: Jul 22, 2024, 7:02 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $873.34 million as of July 22, 2024. Its market cap has decreased by -52.52% in one year.
Market Cap
873.34M
Enterprise Value
218.40M
1-Year Change
-52.52%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $5.33B to $873.34M, a decrease of -83.60%. That is a compound annual growth rate of -39.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 873.30M | -47.29% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.37% |
| Dec 31, 2020 | 10.70B | 100.92% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 920.64M |
| Cronos Group | 909.19M |
| Pacira BioSciences | 901.60M |
| Humacyte | 899.08M |
| Harrow Health | 884.90M |
| Perspective Therapeutics | 852.32M |
| Liquidia | 846.66M |
| Healthcare Services Group | 846.20M |